Delta 469 mutation in the type 3 repeat calcium binding domain of cartilage oligomeric matrix protein (COMP) disrupts calcium binding.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 11013461)

Published in Cell Calcium on June 01, 2000

Authors

J Hou1, J A Putkey, J T Hecht

Author Affiliations

1: Department of Pediatrics, University of Texas Houston Medical School, Houston, USA.

Articles by these authors

(truncated to the top 100)

Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet (1995) 2.43

A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet (1995) 2.30

Bacterial expression and characterization of proteins derived from the chicken calmodulin cDNA and a calmodulin processed gene. J Biol Chem (1985) 2.20

A natural history of cleidocranial dysplasia. Am J Med Genet (2001) 2.14

Nonsyndromic cleft lip with or without cleft palate: evidence of linkage to BCL3 in 17 multigenerational families. Am J Hum Genet (1995) 2.12

Natural history study of hereditary multiple exostoses. Am J Med Genet (1995) 2.09

Chicken calmodulin genes. A species comparison of cDNA sequences and isolation of a genomic clone. J Biol Chem (1983) 1.98

The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nat Genet (1996) 1.87

A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet (1993) 1.67

Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory domain. J Biol Chem (1997) 1.61

Genetic epidemiology study of idiopathic talipes equinovarus. Am J Med Genet (1998) 1.57

Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes. J Biol Chem (2000) 1.34

Mortality in achondroplasia. Am J Hum Genet (1987) 1.33

Segregation analysis of idiopathic talipes equinovarus in a Texan population. Am J Med Genet (1998) 1.32

Domain organization of chicken gizzard myosin light chain kinase deduced from a cloned cDNA. Biochemistry (1986) 1.31

Down-regulation of fast-twitch skeletal muscle fiber with cardiac troponin-C and recombinant mutants. Structure/function studies with site-directed mutagenesis. FEBS Lett (1989) 1.28

Pseudoachondroplasia and multiple epiphyseal dysplasia: New etiologic developments. Am J Med Genet (2001) 1.27

The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. Am J Med Genet A (2008) 1.25

Characterization of a novel gene disrupted by a balanced chromosomal translocation t(2;19)(q11.2;q13.3) in a family with cleft lip and palate. Genomics (1998) 1.24

Delineation of a contiguous gene syndrome with multiple exostoses, enlarged parietal foramina, craniofacial dysostosis, and mental retardation, caused by deletions in the short arm of chromosome 11. Am J Hum Genet (1996) 1.23

Dominantly inherited cleft lip and palate. J Med Genet (1990) 1.16

A mechanism for calmodulin (CaM) trapping by CaM-kinase II defined by a family of CaM-binding peptides. J Biol Chem (1998) 1.15

The role of cartilage oligomeric matrix protein (COMP) in skeletal disease. Curr Drug Targets (2008) 1.14

Natural history study of pseudoachondroplasia. Am J Med Genet (1996) 1.10

Mosaicism in pseudoachondroplasia. Am J Med Genet (1997) 1.09

Recessive multiple epiphyseal dysplasia (rMED): phenotype delineation in eighteen homozygotes for DTDST mutation R279W. J Med Genet (2003) 1.07

Familial interstitial deletion 11(p11.12p12) associated with parietal foramina, brachymicrocephaly, and mental retardation. Am J Med Genet (1993) 1.05

Bepridil opens the regulatory N-terminal lobe of cardiac troponin C. Proc Natl Acad Sci U S A (2000) 1.05

Refinement of the multiple exostoses locus (EXT2) to a 3-cM interval on chromosome 11. Am J Hum Genet (1995) 1.05

The fate of cartilage oligomeric matrix protein is determined by the cell type in the case of a novel mutation in pseudoachondroplasia. J Biol Chem (1997) 1.04

The kinetic cycle of cardiac troponin C: calcium binding and dissociation at site II trigger slow conformational rearrangements. Protein Sci (1998) 1.04

Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes. Cell Motil Cytoskeleton (2001) 1.04

Mild manifestations of the Morquio syndrome. Am J Med Genet (1984) 1.03

The structural organization of the chicken calmodulin gene. J Biol Chem (1985) 1.02

Neurological basis of respiratory complications in achondroplasia. Ann Neurol (1988) 1.02

Long-term neurological sequelae in achondroplasia. Eur J Pediatr (1984) 1.00

Identification of binding sites for bepridil and trifluoperazine on cardiac troponin C. J Biol Chem (1998) 0.99

Genetically engineered calmodulins differentially activate target enzymes. J Biol Chem (1986) 0.98

Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations. J Bone Miner Res (2000) 0.98

Apoptosis staining in cultured pseudoachondroplasia chondrocytes. Apoptosis (2003) 0.98

Evidence for locus heterogeneity in the Camurati-Engelmann (DPD1) Syndrome. Clin Genet (2001) 0.98

Identification of twelve mutations in cartilage oligomeric matrix protein (COMP) in patients with pseudoachondroplasia. Am J Med Genet (1998) 0.96

Model systems for studying skeletal dysplasias caused by TSP-5/COMP mutations. Cell Mol Life Sci (2008) 0.96

Identification of nine novel mutations in cartilage oligomeric matrix protein in patients with pseudoachondroplasia and multiple epiphyseal dysplasia. Am J Med Genet (1999) 0.96

Interaction of cardiac troponin C with Ca(2+) sensitizer EMD 57033 and cardiac troponin I inhibitory peptide. Biochemistry (2000) 0.96

Computerized tomography of the foramen magnum: achondroplastic values compared to normal standards. Am J Med Genet (1985) 0.95

Bacterially synthesized vertebrate calmodulin is a specific substrate for ubiquitination. J Biol Chem (1987) 0.94

Recurrent unilateral hand malformations in siblings. Clin Genet (1981) 0.94

Mutation of the high affinity calcium binding sites in cardiac troponin C. J Biol Chem (1992) 0.94

Hereditary multiple exostoses: confirmation of linkage to chromosomes 8 and 11. Am J Med Genet (1996) 0.94

Genetic heterogeneity in multiple epiphyseal dysplasia. Am J Hum Genet (1995) 0.92

NMR studies of a complex of deuterated calmodulin with melittin. Proc Natl Acad Sci U S A (1986) 0.92

The Schinzel syndrome in a mother and daughter. Clin Genet (1984) 0.92

Chimeric calmodulin-cardiac troponin C proteins differentially activate calmodulin target enzymes. J Biol Chem (1990) 0.92

Nonsyndromic cleft lip with or without cleft palate: erratum. Am J Hum Genet (1996) 0.91

Molecular analysis of overlapping chromosomal deletions in patients with Langer-Giedion syndrome. Genomics (1991) 0.91

The low-affinity Ca2(+)-binding sites in cardiac/slow skeletal muscle troponin C perform distinct functions: site I alone cannot trigger contraction. Proc Natl Acad Sci U S A (1990) 0.90

Short-latency somatosensory evoked potentials in the management of patients with achondroplasia. Neurology (1984) 0.90

Neuroanatomic and neuropsychological outcome in school-age children with achondroplasia. Am J Med Genet (1999) 0.90

Studies of TBX4 and chromosome 17q23.1q23.2: an uncommon cause of nonsyndromic clubfoot. Am J Med Genet A (2012) 0.90

Nonsyndromic cleft lip and palate is not associated with cancer or other birth defects. Am J Med Genet (2000) 0.89

Nonsyndromic cleft lip with or without cleft palate: new BCL3 information. Am J Hum Genet (1996) 0.89

Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFβ-responsive gene. Osteoarthritis Cartilage (2011) 0.88

Familial case of Potocki-Shaffer syndrome associated with microdeletion of EXT2 and ALX4. Clin Genet (2001) 0.88

Differential recovery of Ca2+ binding activity in mutated EF-hands of cardiac troponin C. J Biol Chem (1993) 0.88

Growth hormone therapy in achondroplasia. Am J Med Genet (1992) 0.87

Association of AXIN2 with non-syndromic oral clefts in multiple populations. J Dent Res (2012) 0.87

Evidence, from family studies, for linkage disequilibrium between TGFA and a gene for nonsyndromic cleft lip with or without cleft palate. Am J Hum Genet (1994) 0.87

The effect of pH on the Ca2+ affinity of the Ca2+ regulatory sites of skeletal and cardiac troponin C in skinned muscle fibres. J Muscle Res Cell Motil (1997) 0.87

SSCP and segregation analysis of the human type X collagen gene (COL10A1) in heritable forms of chondrodysplasia. Am J Hum Genet (1992) 0.87

Domain II of calmodulin is involved in activation of calcineurin. FEBS Lett (1988) 0.86

Characterization of human DSPG3, a small dermatan sulfate proteoglycan. Genomics (1996) 0.86

Conformational changes in the metal-binding sites of cardiac troponin C induced by calcium binding. Biochemistry (1992) 0.86

Xeroderma pigmentosum and Cockayne syndrome: overlapping clinical and biochemical phenotypes. Am J Hum Genet (1992) 0.85

Drug binding to cardiac troponin C. J Biol Chem (1999) 0.85

Assignment and calcium dependence of methionyl epsilon C and epsilon H resonances in cardiac troponin C. Biochemistry (1994) 0.84

Foramen magnum stenosis in homozygous achondroplasia. Eur J Pediatr (1986) 0.84

No evidence supporting MTHFR as a risk factor in the development of familial NSCLP. Am J Med Genet (2000) 0.84

Standard weight for height curves in achondroplasia. Am J Med Genet (1996) 0.84

Analysis of the promoter region of human cartilage oligomeric matrix protein (COMP). Matrix Biol (2001) 0.83

Van der Woude syndrome and nonsyndromic cleft lip and palate. Am J Hum Genet (1992) 0.83

The nontranscribed chicken calmodulin pseudogene cross-hybridizes with mRNA from the slow-muscle troponin C gene. Mol Cell Biol (1987) 0.83

Comparative NMR studies on cardiac troponin C and a mutant incapable of binding calcium at site II. Biochemistry (1991) 0.83

Bacterial expression vectors for calmodulin. Methods Enzymol (1987) 0.83

Exclusion of retinoic acid receptor and a cartilage matrix protein in non-syndromic CL(P) families. J Med Genet (1995) 0.83

The interaction of 1,25-dihydroxyvitamin D3 with its intestinal mucosa receptor: kinetic parameters and structural requirements. Lipids (1978) 0.82

Confirmatory linkage of hypochondroplasia to chromosome arm 4p. Am J Med Genet (1995) 0.81

Limb deficiency syndrome in half-sibs. Clin Genet (1981) 0.81

Expanding the phenotype of the 8344 transfer RNAlysine mitochondrial DNA mutation. Neurology (1998) 0.81

An NMR and spin label study of the effects of binding calcium and troponin I inhibitory peptide to cardiac troponin C. Protein Sci (1995) 0.81

Calcium plays distinctive structural roles in the N- and C-terminal domains of cardiac troponin C. J Biol Chem (1993) 0.81

Confirmation of the mapping of the Camurati-Englemann locus to 19q13. 2 and refinement to a 3.2-cM region. Genomics (2000) 0.80

Cleft lip with or without cleft palate: effect of family history on reproductive planning, surgical timing, and parental stress. Cleft Palate Craniofac J (1998) 0.80

Vitamin D-mediated intestinal calcium transport. Effects of essential fatty acid deficiency and spin label studies of enterocyte membrane lipid fluidity. Biochim Biophys Acta (1982) 0.79

Analysis of the chondroitin sulfate proteoglycan core protein (CSPGCP) gene in achondroplasia and pseudoachondroplasia. Am J Hum Genet (1991) 0.79

Tibial hemimelia syndrome: prenatal diagnosis by real-time ultrasound. Prenat Diagn (1994) 0.79

DTDST mutations are not a frequent cause of idiopathic talipes equinovarus (club foot). J Med Genet (2002) 0.79

Genomic characterization of human DSPG3. Genome Res (1999) 0.79

Repeat polymorphisms in human fibrillin genes on chromosome 15 (FBN1) and chromosome 5 (FBN2). Hum Mol Genet (1993) 0.78

Localization of the homolog of a mouse craniofacial mutant to human chromosome 18q11 and evaluation of linkage to human CLP and CPO. Genomics (1996) 0.78